Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome

David M. Safley, Steven P. Marso

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Diabetes mellitus has reached epidemic proportions worldwide. Patients with diabetes are at increased risk for acute coronary syndromes, and these syndromes lead to frequent morbidity and cardiovascular mortality. Emerging adjunctive pharmacological strategies coupled with the drug-eluting stent platform have resulted in improved adverse event rates for this high-risk group. This review will concentrate on the historical data associated with acute coronary syndromes in diabetes mellitus, focusing on revascularisation, drug-eluting stents and antiplatelet therapies.

Original languageEnglish (US)
Pages (from-to)128-135
Number of pages8
JournalDiabetes and Vascular Disease Research
Volume2
Issue number3
StatePublished - Oct 2005

Fingerprint

Drug-Eluting Stents
Percutaneous Coronary Intervention
Acute Coronary Syndrome
Diabetes Mellitus
Pharmacology
Morbidity
Mortality
Therapeutics

Keywords

  • Acute coronary syndromes
  • Antiplatelet therapy
  • Diabetes
  • Drug-eluting stents
  • Percutaneous coronary intervention

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome. / Safley, David M.; Marso, Steven P.

In: Diabetes and Vascular Disease Research, Vol. 2, No. 3, 10.2005, p. 128-135.

Research output: Contribution to journalArticle

@article{d2b3961864c841edac2a51238933ce01,
title = "Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome",
abstract = "Diabetes mellitus has reached epidemic proportions worldwide. Patients with diabetes are at increased risk for acute coronary syndromes, and these syndromes lead to frequent morbidity and cardiovascular mortality. Emerging adjunctive pharmacological strategies coupled with the drug-eluting stent platform have resulted in improved adverse event rates for this high-risk group. This review will concentrate on the historical data associated with acute coronary syndromes in diabetes mellitus, focusing on revascularisation, drug-eluting stents and antiplatelet therapies.",
keywords = "Acute coronary syndromes, Antiplatelet therapy, Diabetes, Drug-eluting stents, Percutaneous coronary intervention",
author = "Safley, {David M.} and Marso, {Steven P.}",
year = "2005",
month = "10",
language = "English (US)",
volume = "2",
pages = "128--135",
journal = "Diabetes and Vascular Disease Research",
issn = "1479-1641",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome

AU - Safley, David M.

AU - Marso, Steven P.

PY - 2005/10

Y1 - 2005/10

N2 - Diabetes mellitus has reached epidemic proportions worldwide. Patients with diabetes are at increased risk for acute coronary syndromes, and these syndromes lead to frequent morbidity and cardiovascular mortality. Emerging adjunctive pharmacological strategies coupled with the drug-eluting stent platform have resulted in improved adverse event rates for this high-risk group. This review will concentrate on the historical data associated with acute coronary syndromes in diabetes mellitus, focusing on revascularisation, drug-eluting stents and antiplatelet therapies.

AB - Diabetes mellitus has reached epidemic proportions worldwide. Patients with diabetes are at increased risk for acute coronary syndromes, and these syndromes lead to frequent morbidity and cardiovascular mortality. Emerging adjunctive pharmacological strategies coupled with the drug-eluting stent platform have resulted in improved adverse event rates for this high-risk group. This review will concentrate on the historical data associated with acute coronary syndromes in diabetes mellitus, focusing on revascularisation, drug-eluting stents and antiplatelet therapies.

KW - Acute coronary syndromes

KW - Antiplatelet therapy

KW - Diabetes

KW - Drug-eluting stents

KW - Percutaneous coronary intervention

UR - http://www.scopus.com/inward/record.url?scp=28144454217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28144454217&partnerID=8YFLogxK

M3 - Article

C2 - 16334594

AN - SCOPUS:28144454217

VL - 2

SP - 128

EP - 135

JO - Diabetes and Vascular Disease Research

JF - Diabetes and Vascular Disease Research

SN - 1479-1641

IS - 3

ER -